COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 112 filers reported holding COHERUS BIOSCIENCES INC in Q4 2018. The put-call ratio across all filers is 2.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $36,578 | -42.6% | 21,143 | -20.7% | 0.00% | – |
| Q1 2024 | $63,725 | -19.0% | 26,663 | +12.8% | 0.00% | – |
| Q4 2023 | $78,704 | +9.9% | 23,635 | +23.5% | 0.00% | – |
| Q3 2023 | $71,587 | -6.0% | 19,141 | +7.3% | 0.00% | – |
| Q2 2023 | $76,185 | -29.6% | 17,842 | +12.8% | 0.00% | – |
| Q1 2023 | $108,222 | -23.2% | 15,822 | -11.1% | 0.00% | – |
| Q4 2022 | $140,921 | -10.8% | 17,793 | +8.4% | 0.00% | -100.0% |
| Q3 2022 | $158,000 | +35.0% | 16,412 | +1.6% | 0.00% | – |
| Q2 2022 | $117,000 | -59.5% | 16,148 | -27.9% | 0.00% | -100.0% |
| Q1 2022 | $289,000 | -33.1% | 22,408 | -17.0% | 0.00% | 0.0% |
| Q4 2021 | $432,000 | +2.6% | 27,010 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $421,000 | -5.2% | 26,191 | -18.3% | 0.00% | 0.0% |
| Q2 2021 | $444,000 | +9.9% | 32,070 | +15.9% | 0.00% | 0.0% |
| Q1 2021 | $404,000 | -8.4% | 27,680 | +9.1% | 0.00% | -50.0% |
| Q4 2020 | $441,000 | +21.8% | 25,369 | +28.4% | 0.00% | 0.0% |
| Q3 2020 | $362,000 | +0.3% | 19,753 | -2.3% | 0.00% | 0.0% |
| Q2 2020 | $361,000 | +67.1% | 20,221 | +51.9% | 0.00% | 0.0% |
| Q1 2020 | $216,000 | -49.3% | 13,310 | -43.7% | 0.00% | 0.0% |
| Q4 2019 | $426,000 | -18.9% | 23,649 | -8.8% | 0.00% | -33.3% |
| Q3 2019 | $525,000 | -7.7% | 25,935 | +0.7% | 0.00% | 0.0% |
| Q2 2019 | $569,000 | +43.0% | 25,745 | -11.7% | 0.00% | +50.0% |
| Q1 2019 | $398,000 | +54.3% | 29,171 | +2.3% | 0.00% | 0.0% |
| Q4 2018 | $258,000 | -54.0% | 28,525 | -16.1% | 0.00% | -50.0% |
| Q3 2018 | $561,000 | +16.6% | 34,006 | -1.1% | 0.00% | +33.3% |
| Q2 2018 | $481,000 | +32.9% | 34,369 | +5.0% | 0.00% | +50.0% |
| Q1 2018 | $362,000 | +11.4% | 32,730 | -11.3% | 0.00% | 0.0% |
| Q4 2017 | $325,000 | -31.0% | 36,914 | +4.7% | 0.00% | -50.0% |
| Q3 2017 | $471,000 | +10.6% | 35,255 | +18.6% | 0.00% | 0.0% |
| Q2 2017 | $426,000 | -35.4% | 29,715 | -4.7% | 0.00% | -42.9% |
| Q1 2017 | $659,000 | -30.3% | 31,180 | -7.1% | 0.01% | -30.0% |
| Q4 2016 | $945,000 | +14.4% | 33,575 | +8.8% | 0.01% | -16.7% |
| Q3 2016 | $826,000 | +49.4% | 30,860 | -5.7% | 0.01% | +71.4% |
| Q2 2016 | $553,000 | -18.2% | 32,741 | +2.9% | 0.01% | -22.2% |
| Q1 2016 | $676,000 | -15.2% | 31,829 | -8.3% | 0.01% | -10.0% |
| Q4 2015 | $797,000 | – | 34,708 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,100,000 | $1,903,000 | 1.75% |
| AlphaCentric Advisors LLC | 1,000,000 | $1,730,000 | 1.27% |
| Tejara Capital Ltd | 1,030,386 | $1,782,568 | 0.65% |
| Rubric Capital Management LP | 10,400,000 | $17,992,000 | 0.47% |
| Birchview Capital, LP | 270,000 | $467,100 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 1,050,000 | $1,816,500 | 0.18% |
| Bridge City Capital, LLC | 316,009 | $546,696 | 0.18% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $5,252,413 | 0.16% |
| Tyche Wealth Partners LLC | 215,902 | $373,510 | 0.09% |
| Pennant Investors, LP | 168,100 | $290,813 | 0.08% |